An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome

Clinical trial NCT00809965 · COMPLETED

Trial details

NCT number: NCT00809965
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Coronary Syndrome Myocardial Infarction Myocardial Ischemia Unstable Angina

Start date: 2008-11-01
Primary completion: 2011-09-01
Enrollment: 15526

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.